FILTERED RESULTS
FILTERS
Ads Top
DARK MODE
CHART
    Filters
      Symbols
      Sentiment
      Impact
      Search
      FILTERED RESULTS

        

      Upgrade your plan
      Dashboard

      Moderna, Merck Shares Surge After Melanoma Vaccine Study Success

      Moderna Inc. and Merck & Co. said their personalized cancer vaccine helped cut the recurrence of melanoma in a large, late-stage trial, an important milestone for the mRNA-based therapy.

      Source: Bloomberg
      .

      Terra Founder Do Kwon Sentenced to 15 Years in Prison for Fraud